Agilon Health, Inc.
AGL · Price history
Price at last available close
$91.00
+$12.85 (+16.44%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Agilon Health, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits.
How they make money
Agilon Health operates a value-based care model by partnering with community-based physician groups to transition their Medicare-centric business to a globally capitated model. The company provides a platform of technology, capital, and clinical support, entering into risk-bearing agreements with health plan payors to share in the savings generated from improved patient outcomes and reduced medical costs.
Products & services
The company provides a platform that includes clinical data analytics, administrative support, and capital to enable physician groups to manage Medicare Advantage and other value-based care populations.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
The company's business is dependent on contracts with health plan payors and CMS; specific concentration details are disclosed in the risk factors of the 2025 10-K.
Suppliers, materials & equipment
- Health plan payors — Various health insurance companies that enter into risk-bearing, global capitation agreements with the company's risk-bearing entities.Source
Strengths
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
26
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
30
Poor
Financial Strength
31
Business Quality / Moat
33
Management
40
Growth Quality
18
Risk / Durability
15
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
36
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
48/100
Building Historical Record
Model Score 48/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Recent buyback activity is present
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for AGL
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving AGL's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •How long can AGL fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is AGL likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What specifically needs to improve for AGL to reach sustainable profitability?
- •What future growth or profitability would be needed to justify AGL's current valuation?
Essential Investment Snapshot
Wall Street Score
26
Opportunity Score
36
Market Cap
$1.53B
P/E Ratio
-5.2
EPS
$-15.38
52-Week High
$133.04
52-Week Low
$7.48
Beta
3.04
Analyst Target
$112.00
Shares Outstanding
16.6M
Total Revenue
$5.92B
Total Debt
$33.4M
Dividend
No current dividend
Liquidation Value / Share
$13.74
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Building upward momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for AGL
Detected from reported data — verify before acting.Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Debt service risk
Interest coverage is low (~-63.4x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on AGL.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Long-term partnership model with community-based physician groups.
- +Purpose-built platform for value-based care transition.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
- −Dependence on Medicare Advantage and CMS reimbursement models.
- −Operational risks associated with medical cost trends and capitation performance.
- −Negative free cash flow may increase the need for outside financing and dilution.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
26
Sep 8, 2026
Change
+0.4
points
Current Score
26
Oct 1, 2026
Category Changes
AGL increased 0.4 points because Asset improved by 2.6 points, Capital improved by 3 points.
Positive Contributors
- + Asset improved by 2.6 points
- + Capital improved by 3 points
Projected Score
Projected Score
28
Projected Change
+1.4 points
Preliminary comparable-period financial changes suggest improvement of approximately 1.4 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$91.00
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.92B | $5.93B | $6.06B | $4.32B | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $5.92B | $6.12B | $6.06B | $4.25B | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $82K | -$188.6M | $4.8M | $69.7M | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $259.0M | $238.5M | $268.9M | $285.8M | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $265.2M | $232.5M | $297.0M | $301.8M | ···· | ···· | ···· | ···· | ···· |
| EBITDA | -$234.0M | -$368.9M | -$218.2M | -$167.6M | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$265.1M | -$421.1M | -$292.1M | -$232.1M | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $3.4M | $6.6M | $6.2M | $6.7M | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$250.6M | -$404.1M | -$248.8M | -$194.5M | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $590K | $1.3M | $1.5M | $791K | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$251.2M | -$405.3M | -$260.2M | -$262.6M | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-15.38 | $-24.50 | $-15.75 | $-16.00 | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 16.70M | 16.56M | 16.44M | 16.36M | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 17.21M | 16.56M | 16.44M | 16.36M | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$1.49B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$1.04
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-19.2%
Cash Change
-37.5%
Margin Change
+8.7 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Debt reduced
What Weakened
- Cash position declined
Potential Score Impact
Positive indicators included revenue growth, debt levels, net income margin. Pressure indicators included EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 7.2%. EPS declined 116.6%. Cash declined 37.5%. Total debt declined 19.2%. Net income margin improved by 8.7 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Log in to view dividend history.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
5 historical recordsHistorical Score Chart
3 of 5 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Care FacilitiesNews
Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Head to Head Survey: Agilon Health (NYSE:AGL) and Fulgent Genetics (NASDAQ:FLGT)
Head to Head Comparison: Agilon Health (NYSE:AGL) & INVO Fertility (NASDAQ:IVF)
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Rumor Mill · AGL
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial